Jasper Therapeutics
JSPR
JSPR
24 hedge funds and large institutions have $69.6M invested in Jasper Therapeutics in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 25 → 24 (-1)
57% less capital invested
Capital invested by funds: $161M → $69.6M (-$91.1M)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Holders
24
Holding in Top 10
3
Calls
$801K
Puts
$48K
Top Buyers
1 | +$2.4M | |
2 | +$118K | |
3 | +$107K | |
4 |
State Street
Boston,
Massachusetts
|
+$77K |
5 |
Renaissance Technologies
New York
|
+$39K |
Top Sellers
1 | -$3.39M | |
2 | -$1.03M | |
3 | -$183K | |
4 |
VF
Virtu Financial
New York
|
-$163K |
5 |
Millennium Management
New York
|
-$156K |